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Pseudomonas aeruginosa are noscomially acquired, opportunistic pathogens that
pose a major threat to the health of burns patients and the immunocompro-
mised. We sequenced the genomes of P. aeruginosa isolates RNS_PA1,
RNS_PA46 and RNS_PAE05, which displayed resistance to almost all frontline
antibiotics, including gentamicin, piperacillin, timentin, meropenem, ceftazi-
dime and colistin. We provide evidence that the isolates are representatives of
P. aeruginosa sequence type (ST) 235 and carry Tn6162 and Tn6163 in genomic
islands 1 (GI1) and 2 (GI2), respectively. GI1 disrupts the endA gene
at precisely the same chromosomal location as in P. aeruginosa strain VR-143/
97, of unknown ST, creating an identical CA direct repeat. The class 1 integron
associatedwith Tn6163 inGI2 carries a blaGES-5–aacA4–gcuE15–aphA15 cassette
array conferring resistance to carbapenems and aminoglycosides. GI2 is flanked
by a 12 nt direct repeatmotif, abuts a tRNA-gly gene, and encodes proteinswith
putative roles in integration, conjugative transfer as well as integrative conjuga-
tive element-specific proteins. This suggests that GI2 may have evolved from a
novel integrative conjugative element. Our data provide further support to the
hypothesis that genomic islands play an important role in de novo evolution of
multiple antibiotic resistance phenotypes in P. aeruginosa.1. Introduction
Pseudomonas aeruginosa is an opportunistic pathogen and a significant threat to the
health of immunocompromised patients hospitalized for periods longer than
7 days [1]. It is a frequent cause of nosocomially derived infections [2,3]
and can survive on hospital fomites for extended periods [4–7]. Multiple
drug-resistant (MDR), extensively drug-resistant (XDR) and pan-resistant [8,9]
P. aeruginosa linages cause life-threatening infections in nosocomial environments
and severely restrict drug options to treat infection. As such, MDR P. aeruginosa is
expected to contribute significantly to increased rates of morbidity and mortality
in hospital environments in the twenty-first century.
The population structure of P. aeruginosa is described as non-clonal and epi-
demic [10]. Several high-risk clonal lineages including ST111, ST235 and ST175
carry genes that confer resistance to b-lactam antibiotics [10–18] and ST235
clones commonly found inAsia are predominantly associatedwith the dissemina-
tion of IMP type b-lactamase resistance genes [15–17,19–22]. MDR P. aeruginosa
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via the production of molecular class A b-lactamase and class
B b-lactamase (metallo-b-lactamases, MBLs) enzymes pose a
serious threat to the health of humans and animals because
only a limited number of drugs remain available to counteract
infections caused by these pathogens. Genes encoding resist-
ance to the molecular class A b-lactamase, extended-spectrum
b-lactamase (ESBLs) and MBL antibiotics are often carried on
class 1 integrons.
The acquisition of class 1 integrons plays a significant role
in the evolution of strains of P. aeruginosa that are recalcitrant
to combination antibiotic therapy, thereby making them exten-
sively drug-resistant (XDR) [23]. However, class 1 integrons are
defective transposons, and an association with functional
transposons, genomic islands and plasmids is critical for
their dissemination. Within the Enterobacteriaceae, plasmids
play a key role in mobilizing class 1 integrons. In P. aeruginosa,
numerous studies correlate the presence of class 1 integrons
with multiple antibiotic resistance, but the genetic context
surrounding class 1 integrons is often not investigated. Our
earlier studies implicated the important role played by geno-
mic islands in the capture and spread of clustered antibiotic
resistance genes within P. aeruginosa [24–26].
In 2009, we described a 25.5 kb transposon Tn6060, which
contained twooutwardly facing class 1 integrons encoding resist-
ance to eight antibiotics. Tn6060 is found in the res site of a
transposon with more than 99% sequence identity to Tn1403
within a genomic island (described as GI1) on the chromosome
of P. aeruginosa strain 37308 [25]. Novel class 1 integrons and
transposonswere subsequently described in at least four distinct
chromosomal locations among clinical isolates from Australia
and Uruguay [26]. These integrons carried identical cassette
arrays comprising aadA6 (encoding resistance to streptomycin
and spectinomycin) and gcuD (formerly orfD) within a novel
transposon, Tn6162, that is located at precisely the same position
as Tn6060 in GI1. Class 1 integrons harbouring the aadA6-gcuD
array have been reported from geographically divergent regions
including France [27] and in an extensively drug-resistant
P. aeruginosa isolate from Thailand [28], but the genetic context
of the integron-arrays remains unknown. We also described an
Australian P. aeruginosa strain, C79, containing a second-class 1
integron that carries blaGES5 (encoding resistance to extended-
spectrum b-lactams), an aacA4-like gene cassette (encoding
resistance to aminoglycosides), gcuE15 (unknown function),
aphA15 (aminoglycoside resistance) and several IS elements in
genomic island 2 (GI2) [26]. The integron in strain C79 was
found within a mercury resistance transposon Tn4380 known
as Tn6163, also located in a genomic island, described as island
2orGI2 [26].WhileTn6163wasnotdetected in isolates fromUru-
guay, it was identified in seven clonally related clinical isolates of
P. aeruginosa collected from Sydney in 2010 [26]. Although the
structures of transposons Tn6060, Tn6162 and Tn6163 have
been described in detail, the genomic islands harbouring them
were not characterized in any of our previous studies.
In P. aeruginosa strain VR-143/97, the blaVIM-1 metallo-
b-lactamase gene cassette is associated with a class 1 integron
(In70.2) in a defective Tn402-like transposon that is inserted
in the urf2 gene of a Tn3-derivate transposon known as
Tn6249. Like Tn6060, Tn6249 has a complex structure and car-
ries two class 1 integrons (In90 and In70.2) in a tail-to-tail
orientation [29]. Tn6249 is located in a PACS171b-like genomic
island, described earlier as GI1 in relation to Tn6060 [25],
within the endA gene of the P. aeruginosa chromosome [29].Tn6249 shares structural identity with Tn6060, although the
gene cassettes carried by In90 are different and a part of the
Tn3 backbone is missing in Tn6249 [25]. Notably, Tn6162 is
also located at an identical position in the genomic backbone
of GI1 as Tn6060, but has a simpler complex resistance locus
(CRL) consisting of one class 1 integron. Consequently, it has
been hypothesized that insertion of a Tn6162-like ancestor
into the PACS171b-like genomic island (VR-143/97; 51
424 nt) preceded the genetic events that gave rise to Tn6249
and Tn6060 in clonally dispersed lineages of P. aeruginosa [29].
Here we present an in-depth, whole-genome-based analy-
sis of three MDR ST235 isolates carrying both Tn6162 in GI1
and Tn6163 in GI2. All three isolates are resistant to the entire
range of antibiotics used to treat P. aeruginosa infections
except colistin (intermediate resistance to colistin) and are
part of a larger collection of phylogenetically related MDR
isolates recovered in 2006 and 2007 from a burns ward in a
hospital in Sydney. The genetic structure of GI1 and GI2
found in P. aeruginosa isolates in Sydney is presented. Our
study highlights the roles played by GI1 and GI2 in the cap-
ture and dissemination of multiple antibiotic resistance genes
in P. aeruginosa ST235 in the Sydney basin.2. Material and methods
2.1. Strains, isolation and culture conditions
The P. aeruginosa isolates examined in this study were
obtained during an outbreak of a multiple antibiotic-resistant
P. aeruginosa infection at the Royal North Shore Hospital
(RNSH) in the burns unit during 2006 and 2007. Isolates
RNS_PA1 (rectal swab, November 2006), RNS_PA46 (burn
wound, May 2007) and RNS_PAE05 (hand sanitizer, April
2007) were recovered as part of routine microbiological sur-
veillance during the outbreak. The isolates were identified
as P. aeruginosa using standard microbiological protocols
[30] and stored at 2808C.
For molecular studies, the isolates were routinely grown at
378C on Luria–Bertani (LB) agar or overnight in LB broth with
shaking at 125 r.p.m. For antibiotic sensitivity testing, cells
from two to three colonies growing on blood agar were subcul-
tured in tryptone soy broth (TSB) for 3 h at 378Cprior to plating
on antibiotic supplemented Columbia agar. For extraction
of sequencing quality DNA, cells were grown in 5 ml of
M63 minimal salts broth for 20 h at 378C in a shaking incuba-
tor set at 125 r.p.m., harvested by centrifugation and stored
at 2808C.
2.2. DNA extraction
Genomic DNA for PCR was extracted from 200 ml of a TSB
culture inoculated with several colonies from blood agar
plates. DNA was extracted on a BioRobot M48 workstation
(Qiagen) at RNSH following the manufacturer’s instructions.
For next-generation genomic sequencing, DNA samples
were extracted using Bioline’s ISOLATE-II Genomic DNA
extraction kit following recommended protocols.
2.3. RAPD analysis
RAPD analysis was conducted using puRe Taq Ready-To-Go
PCR beads (GE Healthcare) with 20 ng of template DNA,
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and visualized on a QIAxcel (Qiagen) 12-channel capillary
electrophoresis system. Data were exported to BIONUMERICS 6
(Applied Maths) software for comparison and analysis.
2.4. PCR
Routine PCR was conducted in a total volume of 20 ml using
Mango Taq (Bioline) master mix. Cycling conditions com-
prised an initial denaturation step at 948C for 2 min 30 s,
followed by 30 cycles of denaturation (948C for 30 s) annealing
(608C for 30 s) and extension (728C for 5 min). An Emerald-
Amp Taq polymerase (Master Mix) was used in long-range
PCR to bridge Illumina sequence scaffolds. Primer sequences
and amplicon sizes are listed in electronic supplementary
material, table S1.
2.5. Antibiotic resistance testing
Antibiotic resistance profiles were generated following the
CLSI guidelines [32]. Plates were incubated overnight at
378C. The antibiotic concentration at which colony growth
was inhibited was noted as the minimum inhibitory concen-
tration (MIC). Reference strains used in the experiment were
P. aeruginosa ATCC27853 and E. coli ATCC25922.
2.6. Sanger sequencing and whole genome sequencing
Promega Wizard SV PCR and Gel Clean Up kits were used to
prepare PCR amplicons for sequencing. Sanger sequencing
was performed at the Australian Genome Research Facility
at Westmead Hospital, Westmead, NSW.
Genome sequencing was performed using a bench top
Illumina MiSeq sequencer and MiSeq V3 chemistry at
the ithree institute at UTS [33]. Genomes were submitted
to GenBank using the following accession numbers:
RNS_PA1 (SAMN04038435), RNS_PA46 (SAMN04038437)
and RNS_PAE05 (SAMN04038440). 400 nt Illumina reads
were assembled using the A5-MiSeq (ngopt_a5pipeline_
linux-x64_20130919) de novo assembly pipeline [34]. Prelimi-
nary genome annotations were performed with an online
version of RAST [35,36] using FigFAM release 70. Sequences
of interest from the preliminary annotation were manually
curated using iterative NCBI-ORF finder software coupled
with BLASTn and BLASTp analysis. ORFs that returned
identity across 100% of the input query sequence in
BLASTp analysis were scored.
2.7. Bioinformatic analysis
Phylogenetic comparisons of the three P. aeruginosa genomes
(RNS_PA1, RNS_PA46 and RNS_PAE05) with nine completely
closed P. aeruginosa genomes available in NCBI (accessed on
3 September 2015) was performed using PHYLOSIFT [37].
Genome sequences of Vibrio cholerae N16961 (NC_002505.1)
and Salmonella enterica serovar typhimurium DT104
(NC_022569.1) were used as outgroups in the analysis. FIGTREE
v. 1.4.0 (http://tree.bio.ed.ac.uk/software/figtree/) was used
to draw the phylogenetic tree. Two closely related, finished
genomes (PA_NCGM2 and PA_PA14) were chosen from
the PHYLOSIFT output and used to do a second phylogenetic
analysis based on the whole genome alignment protocol in
REALPHY [38].The MLST database (http://pubmlst.org/paeruginosa/)
was used to identify the sequence type (ST) of the isolates.
Whole genome comparative analysis was performed using
MAUVE [39], and regions of interest between the three gen-
omes were further characterized using iterative BLASTn
and BLASTp searches [40]. Figures were compiled using
BRIG [41].3. Results
3.1. Characterization of three multiple drug-resistant
Pseudomonas aeruginosa isolates from the Royal
North Shore Hospital burns unit
The three MDR P. aeruginosa isolates examined in this study
were representative of a collection of 36 isolates from RNSH
that shared 90% similarity by RAPD analyses (electronic sup-
plementary material, figure S1). PCR analyses indicated that
all 36 isolates carried a class 1 integron and a characteristic
1800 bp cassette array amplicon akin to the array present in
Tn6162. The amplicon was shown to contain aadA6 and
gcuD gene cassettes by nested PCR using a primer pair that
internally annealed to the aadA6 (HS513) and gcuD (gcuD-
Rv) genes, confirming that these isolates carry Tn6162. Of
the 36 isolates, 27 also produced a 2407 bp amplicon using
a forward primer (HS1299) in blaGES-5 and reverse primer
(HS1236) in aphA15. The 2407 bp amplicon is indicative of
the presence of Tn6163 containing blaGES-5–aacA4–gcuE15–
aphA15 gene cassettes [26]. Isolates included in this study
were tested for sensitivity to antibiotics used at RNSH to
treat P. aeruginosa infections, including gentamicin, piperacil-
lin, ticarcillin and clavulanic acid, meropenem, ceftazidime
and colistin (table 1). Defining features of the three isolates
selected for genome sequence analysis were (i) that they
were isolated from different patients/sources at the RNSH
over a seventh month period, (ii) that they displayed minor
differences in their resistance profile and intermediate resist-
ance to colistin (table 1), a last line treatment option for
P. aeruginosa infections, and (iii) a suspicion that they carried
Tn6162 and Tn6163 using the PCR strategy described above.
As such, these three isolates represent a set that predates (by 4
years) strains from which Tn6162 and Tn6163 were originally
described in Australia [26] from a different hospital in the
Sydney basin.
3.2. Phylogenetic analysis of the three isolates
Raw reads were assembled (assembly statistics in electronic
supplementary material, table S2) using the A5 pipeline [34]
yielding approximately 170 scaffolds with an average of
35–38  coverage and N50 scores from 99 078 to 111 819 nt.
The three P. aeruginosa genomes (RNS_PA1, RNS_PA46 and
RNS_PAE05)were comparedwith 18 finishedPseudomonas gen-
omes deposited in GenBank using PHYLOSIFT. Two of the three
isolates (RNS_PA1 and RNS_PA46) clustered in a single clade
with P. aeruginosa isolate NCGM2 (electronic supplementary
material, figure S2). PHYLOSIFT infers phylogenetic relationships
within bacterial populations based on the amino acid sequence
identity of 37 conserved core marker genes [37]. The branch that
clustered RNS_PA1, RNS_PA46 with NCGM2 displayed a con-
fidence value of 0.92, indicating that P. aeruginosaNCGM2 is the
Table 1. Antibiotic resistance profiles of P. aeruginosa isolates. R, resistant to antibiotic; I, intermediate resistance to antibiotic; S, susceptible to antibiotic;
number in parentheses is the MIC in ml ml21. GEN, gentamicin (aminoglycoside); PIP, piperacillin (extended-spectrum b-lactam); TCA, ticracillin [b-lactam]/
clavulanic acid [b-lactamase inhibitor]; MPM, meropenem (carbapenem); CAZ, ceftazidime (third-generation cephalosporin); COL, colistin (polymixin E).
isolate GENa PIPb TCAc MPMd CAZe COLf
RNS_PA1 R (.32) R (.256) R (128/2) R (64) R (32) I (4)
RNS_PA46 R (.32) R (128) R (128/2) R (128) R (32) I (4)
RNS_PAE05 R (.32) R (128) R (128/2) R (128) R (32) I (4)
aS  4, I ¼ 8, R  16.
bS  64, R  128.
cS  64/2, R  128/2.
dS  4, I ¼ 8, R  16.
eS  8, I ¼ 16, R  32.
fS  2, I ¼ 4, R  8.
PA_c7447m
PA_PAO581
PA_PAO1
PA_DK2
PA_RP73
PA_SCV20265
PA_M18
PA_LESB58
PA_LES431
PA_PA1
PA_PA1R
PA_B136
PA_MTB
PA_UCBPP_PA14
PA_NCGM1984
PA_NCGM1900
PA_NCGM2
100
100
100
100
95
0.0020
100100
100
100
100
100
100
100
100
77
96
14
99
RNS_PA1
RNS_PAE05
RNS_PA46
Figure 1. Phylogenetic tree based on whole genome alignments created using REALPHY.
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lyses. Isolate RNS_PAE05, from the hand sanitizer bottle,
resided on a separate clade. eMLST analysis [42] of NCGM2
and all three of our isolates showed that they belong to ST235.
P. aeruginosa isolate PA14 resides in a clade that shares a
common ancestral node with RNS_PA1, RNS_PA46 and
NCGM2. PA14 belongs to the ST253 clade and is amultiple anti-
biotic-resistant clinical isolate implicated in a wide variety of
diseases [43]. All 20 isolates branching out of PA_PA7 were
used to set up a whole genome alignment-based phylogenetic
analysis using REALPHY [38]. NCGM2 and PA14 were used
as reference genomes in this analysis. The tree generated by
aligning whole genomes places RNS_PA1, RNS_PA46 and
RNS_PAE05 in a single clade (bootstrap value of 100) and
strain NCGM2 as the closest neighbour (figure 1).3.3. Characterization of genomic islands GI1, GI2 and
exoU in Pseudomonas aeruginosa isolate RNS_PA1
Scaffolds spanning GI1 and GI2 in P. aeruginosa RNS_PA1
were assembled by targeted PCR and Sanger sequencing fol-
lowed by BLASTn alignments with published sequences.
Transposons structures were confirmed using overlapping
PCR experiments (figure 2a and 2b, respectively).
GI1 in RNS_PA1 comprises a 54 840 nt-long DNA seg-
ment and harbours Tn6162. GI1 was originally described as
part of a genomic fragment in clone fa1389 (GenBank acces-
sion: EU595750) from P. aeruginosa isolate PACs171b and
was thought to be restricted to isolates from patients with
cystic fibrosis [44]. An island that contains significant por-
tions of the fa1389 clone was recently found inserted in the
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inserted
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(c)
Figure 2. The PCRs used to link scaffold breaks within the three genomic islands found in isolate RNS_PA1. (a) Tn6162 in GI1, (b) Tn6163 in GI2 and (c) exoU island
with identified insertion element. PCRs shown with primers above the structure and the scaffolds for MS1 shown below each structure. Amplicons were verified using
Sanger sequencing.
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lated from Italy in 1997. We also identified regions within
the fa1389 clone in isolates sourced from patients without
cystic fibrosis in Australia and South America [25,26]. Inser-
tion of the island creates a signature 2 bp (CA) direct repeat
(figure 3a) at the chromosomal insertion site. Tn6162 in our
three isolates is 26 056 nt long and has 99% sequence identity
over 100% of the query sequence to the first described
sequence of Tn6162 (JF826498.1). Our sequence contains
five single nucleotide polymorphisms compared with
Tn6162 described previously. Beyond the CRL, the sequence
of the genomic island is identical at both ends to the GI
sequence from strain VR-143/97 (figure 3a).GI2, which carries Tn6163, was identified on three scaf-
folds. Gap closing PCRs followed by Sanger sequencing
led to the reconstruction of the GI2 sequence (figure 3b;
electronic supplementary material, figure S4). In isolate
RNS_PA1, GI2 (115 604 nt) comprises 94 368 nt of chromoso-
mal backbone (average GþC content 63.5%) and is located
adjacent to a tRNA-gly gene. Tn6163 comprises 21 236 nt
and displays 99% sequence identity to Tn6163 (GenBank
accession JF826499) with 15 SNPs and eight gaps, and is
flanked by the characteristic 5 nt direct CTCAA repeats
(figure 3b). A complete integrase gene (WP_003158602.1)
resides next to the tRNA insertion site. Manual annotation
of the GI2 backbone identified 88 ORFs (electronic
(a)
(b)
Figure 3. Diagrammatic representation of the precise location of the complex resistance loci on the respective genomic islands. (a) Comparison of the complex
resistance loci in Genomic Island 1 in P. aeruginosa strain VR-143/97 and in globally disseminated ST235, and their location in the glycerate kinase gene of GI1.
(b) Complex resistance region of Genomic Island 2, which includes the precise location of Tn6163. Open circles represent 12 bp direct repeat (AACGCCAGGGAA)
generated due to insertion of GI2. Bold diamond depicts 5 bp direct repeat (CTCAA) generated owing to insertion Tn6163.
rsob.royalsocietypublishing.org
Open
Biol.6:150175
6
 on March 16, 2016http://rsob.royalsocietypublishing.org/Downloaded from supplementarymaterial, figure S4). Details of the gene content
in GI2 are presented in electronic supplementary material,
table S3. A 12 nt direct repeat with the sequence AACGC
CAGGGAA flanks the ends of GI2, suggesting that it is
likely to be a recent insertion event at this site. Genes encoding
proteins with roles in integration (integrase), conjugative
transfer aswell as integrative conjugative element-specific pro-
teins are present, indicating that GI2may be a novel integrative
conjugative element.
BLAST analysis of the entire GI2 backbone identified a
match (99% sequence identity) to a region in P. aeruginosa
strain NCGM 1900 (AP104622) suggesting that this strain con-
tains a variant of GI2 (figure 3). Further analysis of the
matching sequence in NCGM 1900 failed to identify any evi-
dence of Tn6163. BLAST alignments also identified a fragment
(99% sequence identity) comprising 26 659 nt from ORF63 to
the end of GI2 in the NCGM2 genome (NC_017549) indicatingthe island, like GI1, is not restricted within P. aeruginosa isolates
collected in Australia.
The exoU genomic island in RNS_PA1 which harbours the
gene encoding the potent cytotoxin ExoU is 83 830 nt in
length and shows 99% sequence identity to the exoU island A
in GenBank entry DQ437742 (81 751 nt). The sequence in
RNS_PA1 differs only by the presence of a 2059 nt insertion
element (figure 2c). The type III secretion system (T3SS) in
P. aeruginosa plays an important role in pathogenicity by trans-
porting effector molecules such as the cytotoxin ExoU into host
cells. The structural components of the T3SS are located on a
23.9 kb region in the PA14 genome and these were aligned to
corresponding regions of the three genomes in our study (elec-
tronic supplementary material, figure S3). RNS_PA1 had 140
SNPs and seven gaps, RNS_PA46 had 134 SNPs and one gap,
and NCGM2 had 140 SNPs and seven gaps, when compared
with the T3SS in PA14. The T3SS in isolate RNS_PAE05 had
100% identity
100% identity
98% identity
95% identity
98% identity
95% identity
100% identity
98% identity
95% identity
tBLASTx_BRIG
6764661 bp
NCGM2vsPA1
NCGM2vsPA46
NCGM2vsPAE05
6500 kbp
6000 kbp
5500 kbp
5000 kbp
4500 kbp
4000 kbp
3500 kbp
3000 kbp
2500 kbp
2000 kbp
1500 kbp
1000 kbp
500 kbp
Figure 4. Comparative tBLASTx analysis of the three P. aeruginosa genomes against the reference NCGM2 genome.
500 000 1 000 000 1 500 000 2 000 000 2 500 000 3 000 000 3 500 000 4 000 000 4 500 000 5 000 000 5 500 000 6 000 000 6 500 000 7 000 000
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500 000 1 000 000 1 500 000 2 000 000 2 500 000 3 000 000 3 500 000 4 000 000 4 500 000 5 000 000 5 500 000 6 000 000 6 500 000 7 000 000
RNS PA46
RNS PA1
1 2 3
RNS E05
Figure 5. Mauve alignments of the RNS_PA1, RNS_PA46 and RNS_PAE05. Black boxes around the green segment in genome RNS_PA1 and RNS_PAE05 represent
parts of scaffold 4 and 8 in the genome sequence, respectively. Blue box 1 in genome RNS_PA46 represents scaffold 27, box 2 represents scaffold 40 and box 3
represents scaffold 77.
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orygene exsC. InVibrio parahemolyticus, deletionof the exsCgene
has been shown to shut down the expression of T3SS [45].
3.4. Comparative genome analysis
All three genomes were tiled against the closed genome
sequence of P. aeruginosa NCGM2. The genome of strain
NCGM2 comprises 6 764 661 nt, and is slightly smaller than
the genomes from RNS_PA1, RNS_PA46 and RNS_PAE05.
tBLASTx analysis comparing whole genomes of RNS_PA1,
RNS_PA46 and RNS_PAE05 independently with NCGM2
(figure 4) identified a major region of difference close to
the 1500 kbp marker. Bi-directional BLASTp analysis com-
paring each of our isolates with NCGM2 identified fourregions of difference containing phage-derived proteins.
These analyses suggest that ST235 isolates derived from
different geographical regions have likely been infected
with different phage populations and have been subjected
to novel phage-mediated genomic rearrangements.
Progressive MAUVE alignment of the three genomes
was used to identify scaffolds that define the core and accessory
genomes in RNS_PA1, RNS_PA46 and RNS_PAE05 (figure 5).
Regions coloured inmagenta represent shared sequence identity
inRNS_PA1,RNS_PA46andRNS_PAE05.Blue-boxedregions in
the core genome of RNS_PA46 are unique to this strain. Scaffold
27 (blue box 1) from strainRNS_PA46 contains genes that encode
proteins relating to a ‘mobile genetic element’ like integrase, con-
jugation proteins and a series of uncharacterized hypothetical
proteins. Scaffolds 40 and 77 (boxes 2 and 3, respectively, in
Table 2. Comparison of SNPs identified in P. aeruginosa isolates included in this study.
SNP indel
individual SNPs clustered SNP groups genes/ORFs with clustered SNPs indels present large indelsa
RNS_PA1 101 2 61 glucose/carbohydrate outer membrane
porin genes
18 riboflavin-specific deaminase/reductases
genes
47 0
RNS_PA46 119 4 34 hypothetical protein
13 putative MFS transporter
10 hypothetical protein
19 hypothetical protein (NCGM2_4844)
49 6
RNS_PAE05 308 11 27 hypothetical protein
18 putative glycerol kinase
96 dnaX
10 isochorismatase family hydrolase
15 putative transmembrane sensor
13 hypothetical protein
15 no ORF
18 no ORF
16 hypothetical protein
18 elongation factor Tu
20 putative gamma-glutamyltranspeptidase
precursor
45 0
aLarge indels defined as larger than 5 kb.
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Electronic supplementary material, table S4 provides a descrip-
tion of the gene content of the unaligned scaffolds generated by
preliminary RAST annotation of regions greater than 1 kb.
In summary, the differences noted in the genomes of
RNS_PA1, RNS_PA46 and RNS_PAE05 appear to be phage-
related and other laterally acquired regions. RNS_PA46 has
the biggest genome, comprising 6672 ORFs, and RNS_PA1 is
the smallest genome, with 6564 predicted ORFs. Table 2
shows a summary of SNPs and indels identified at least
100 nt from a scaffold break. RNS_PAE05 contains the largest
number of SNPs of the three genomes. These data show that
of the functionally defined genes, major SNP differences in
the genomes of RNS_PA1, RNS_PA46 and RNS_PAE05 were
localized within housekeeping genes. For example, the DNA
polymerase gene dnaX, glucose carbohydrate outer membrane
porin gene oprB and riboflavin-specific deaminase reductases
gene ribD exhibited SNPs. However, differences were also
identified in a number of other genes that were annotated as
hypothetical proteins by RAST.3.5. Genomewide identification of resistance and
virulence genes
RNS_PA1, RNS_PA46 and RNS_PAE05 carried identical
variants of all the resistance and virulence genes listed in
table 3. In addition, we also surveyed the ComprehensiveAntibiotic Resistance Database (http://arpcard.mcmaster.ca)
with our genome sequences (electronic supplementary
material, table S5). The repertoire of antibiotic resistance
genes identified in each of the strains is likely to account for
their resistance phenotype. Mutations in phoQ and pmrB are
known to have a role in colistin resistance [46]. In the genomes
of RNS_PA1, RNS_PA46 and RNS_PAE05, an F76Y mutation
in phoQ was identified and is unique to our isolates. We also
identified a V15I mutation in pmrB. This same mutation was
recently reported to alter colistin sensitivity in P. aeruginosa
strain P165 [47]. We speculate that these mutations have
probably contributed to the intermediate colistin resistance
phenotype exhibited in our three Sydney isolates. While the
genome of NCGM2 carries a different suite of resistance
genes to the ones in RNS_PA1, RNS_PA46 and RNS_PAE05,
we cannot comment any further as the resistance profile of
NCGM2 has not been reported.4. Discussion
Previouslywe showed that two genomic islands are implicated
in mobilizing transposons that carry multiple antibiotic resist-
ance genes in clinical isolates of P. aeruginosa [26,48]. Here, we
describe the genetic architecture of two genomic islands impli-
cated in the dissemination of multiple antibiotic resistance
genes in three P. aeruginosa ST235 isolates from Sydney and
provide further evidence supporting our hypothesis that
Table 3. Antibiotic resistance and virulence genes in P. aeruginosa isolates.
antibiotic resistance genes RNS_PA1 RNS_PA46 RNS_PAE05 NCGM2 NCGM 1900
aadA6
(encodes resistance to aminoglycoside)
(JF826498.1: 24 514-25 359)
present
100% nBLAST
present
100% nBLAST
present
100% nBLAST
present
100% nBLAST
aphA15
(encodes resistance to aminoglycosides)
(JF826499.1: 13 868-14 662)
present
100% nBLAST
present
100% nBLAST
present
100% nBLAST
nfxB
(encodes resistance to norfloxacin)
(CP000438.1: 5 428 030–5 428 593)
present
98% nBLAST
100% pBLAST
present
98% nBLAST
100% pBLAST
present
98% nBLAST
100% pBLAST
present
98% nBLAST
100% pBLAST
present
98% nBLAST
100% pBLAST
blaGES-5
(encodes resistance to b-lactam)
(JF826499.1: 11 979–12 842)
present
100% nBLAST
present
100% nBLAST
present
100% nBLAST
ampC
(b-lactam)
(CP000438.1: 932 631–933 824)
present
100% nBLAST
present
100% nBLAST
present
100% nBLAST
present
100% nBLAST
present
99% nBLAST
100% pBLAST
phoQ
(mutations known to cause colistin
resistance)
(AE004091.2: 1 278 362–1 279 708)
present
99% nBLAST
99% pBLAST
F76Y
present
99% nBLAST
99% pBLAST
F76Y
present
99% nBLAST
99% pBLAST
F76Y
present
99% nBLAST
99% pBLAST
F76Y
pmrB
(mutations known to cause colistin
resistance)
(AE004091.2j:5 364 760–5 366 193)
present
99% nBLAST
99% pBLAST
V15I
present
99% nBLAST
99% pBLAST
V15I
present
99% nBLAST
99% pBLAST
V15I
putative virulence genes RNS_PA1 RNS_PA46 RNS_PAE05 NCGM2 NCGM 1900
exoT
(effector of T3SS)
(AE004091.2: 58786–60 159)
present
99% nBLAST
100% pBLAST
present
99% nBLAST
100% pBLAST
present
99% nBLAST
100% pBLAST
present
99% nBLAST
100% pBLAST
present
99% nBLAST
100% pBLAT
exoY
(effector of T3SS)
(AE004091.2: 2 410 344–2 411 480)
present
non-functional
99% nBLAST
stop codon
present in
middle of
sequence
present
non-functional
99% nBLAST
stop codon
present in
middle of
sequence
present
non-functional
99% nBLAST
stop codon
present in
middle of
sequence
present
non-functional
99% nBLAST
stop codon
present in
middle of
sequence
aprA
(extracellular protease)
(AE004091.2: 1 355 631–1 357 070)
present
99% nBLAST
100% pBLAST
present
99% nBLAST
100% pBLAST
present
99% nBLAST
100% pBLAST
present
99% nBLAST
100% pBLAST
present
99% nBLAST
100% pBLAST
lasA
(extracellular protease)
(AE004091.2: 2 410 344–2 411 480)
present
98% nBLAST
100% pBLAST
present
98% nBLAST
100% PBLAST
present
98% nBLAST
100% pBLAST
present
98% nBLAST
100% pBLAST
lasB
(extracellular protease)
(AE004091.2: 4 168 987–4 170 483)
present
98% nBLAST
100% pBLAST
present
98% nBLAST
100% pBLAST
present
98% nBLAST
100% pBLAST
present
98% nBLAST
100% pBLAST
present
98% nBLAST
100% pBLAST
exoU
(acute cytotoxin)
(CP000438.1(PA14): 4 580 957–4 583 020)
present
99% nBLAST
100% pBLAST
present
99% nBLAST
100% pBLAST
present
99% nBLAST
100% pBLAST
present
99% nBLAST
100% pBLAST
present
99% nBLAST
100% pBLAST
(Continued.)
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Table 3. (Continued.)
putative virulence genes RNS_PA1 RNS_PA46 RNS_PAE05 NCGM2 NCGM 1900
ladS
(promotes biofilm formation)
(AE004091.2: 4 453 289–4 455 676)
present
99% nBLAST
100% pBLAST
present
99% nBLAST
100% pBLAST
present
99% nBLAST
100% pBLAST
present
99% nBLAST
100% pBLAST
present
99% nBLAST
100% pBLAST
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tiple antibiotic resistance. We have characterized GI1 in three
Sydney isolates which are representatives of ST235, and the
structure is very similar to the one described recently from iso-
late VR-143/97 from Italy. In addition, we define, for the first
time, both the boundaries of and the genetic composition of
genomic island 2. GI2 was originally proposed to be restricted
to isolates collected from the Sydney basin. However, in this
study, we provide evidence that suggests that GI2 is not
restricted to isolates from a specific geographical location and
may be a characteristic of the ST235 clonal lineage.
In our Sydney isolates, we show that GI1 carries Tn6162
(figure 3) and has inserted into the endA gene at precisely the
same position as a PACS171b-like genomic island in multiple
antibiotic-resistant P. aeruginosa isolate VR-143/97 isolated in
Italy in 1997 [45]. The PACS171b-like genomic island in strain
VR-143/97 harbours Tn6249, a complex transposon carrying
two different class 1 integrons, one of which houses a VIM-1
gene cassette. The genome sequence for strain VR-143/97
has not been released and as such we cannot determine if
VR-143/97 belongs to the ST235 lineage. In Australian isolates
of P. aeruginosa, GI2 harbours Tn6163. Tn6163 contains a class 1
integron with blaGES-5–aacA4–gcuE15–aphA15 gene cassettes.
It is not known if strain VR-143/97 also harbours Tn6163.
Notably, BLAST analysis of the entire GI2 backbone identified
(99% sequence identity) a region in ST235 P. aeruginosa strain
NCGM 1900 raising the possibility that GI2may bewidely dis-
seminated in the ST235 lineage. While GI2 comprises certain
features typical of ICE elements described in other bacteria, it
has clearly undergone genetic rearrangements in the three gen-
omes described in this study. Currently, we do not have any
evidence to indicate GI2 has the capacity to excise from the
genome and transfer elsewhere via conjugation.
The three Australian ST235 isolates carry both GI1 and GI2
and display resistance to almost all frontline antibiotics used
to control infections caused by P. aureginosa at RNSH. Tn6163
harbours a class 1 integron that contains the Ambler class A
b-lactamase gene cassette blaGES-5 that confers resistance to
all b-lactams including carbapenems. It also contains aphA15
that confers resistance to kanamycin and neomycin. The ami-
noglycoside resistance gene aadA6 that confers resistance to
gentamicin forms the first cassette in the array of the class 1
integron in Tn6162.
GI1 appears to have been integrated into the genome by a
phage-integrase-mediated site-specific recombination event.
The PHAST database was interrogated to identify phage
genes that may facilitate movement of the genomic islands
(data not shown), but none were identified. However, given
the number of phage-related genetic signatures in all three
P. aeruginosa genomes, it is possible that parts of GI1 were
originally transferred into P. aeruginosa by a phage which
has subsequently lost function. The exoU island A in our
Australian isolates had 99% sequence identity to the exoUisland present in P. aeruginosa strains NCGM1900 and
NCGM2 from Japan [49]. We identified a novel insertion
sequence in exoU island A that is unique to the Australian iso-
lates of P. aeruginosa described in this study. The closest
match to the insertion sequence is found in the genome of
Pseudomonas putida strain S12 (CP009974). Further work is
needed to determine if the insertion sequence can be used
as a marker to identify the exoU island A variant.
RNS_PA1, RNS_PA46 andRNS_PAE05 carry a comprehen-
sive repertoire of putative virulence genes. In P. aeruginosa, the
T3SS has four known effectors: ExoU, ExoY, ExoT and ExoS.
While clinical isolates have never been shown to carry all four
effectors, ExoT has been identified frequently, suggesting it per-
forms a function in pathogenesis [50]. ExoT is known to inhibit
host-cell division by interrupting cytokinesis in mammalian
cells [50]. In an epithelial cell model, ExoY has adenlylate
cyclase activity that leads to increases in intracellular cAMP
levels and inhibits cellular invasion [51]. ExoU is an important
virulence factor that mediates cell death in macrophages, epi-
thelial cells and fibroblasts [52]. ExoU functions in concert
with its chaperone SpcU, and we identified spcU in the exoU
island A in the genome sequences of all three Sydney isolates.
The T3SS effector proteins play a significant role in causing
severe pneumonia [53]. LasA and LasB possess elastolytic
activity [54], whereas LadS activates a cascade that decreases
cytotoxicity and increases biofilm formation [55]. Finally,
AprA encodes an alkaline protease that is secreted by the
type 1 secretion system [56].
In conclusion, all three Sydney ST235 isolates have the
blaGES-5 gene inserted as a gene cassette within a class 1 inte-
gron that forms part of Tn6163 located in GI2. The genomic
data presented here and elsewhere (AP014622, AP014646
and [29]) show that genomic islands are playing a seminal
role in the dissemination of resistance to a wide range of clini-
cally important antibiotics, including metallo-b-lactams and
extended-spectrum b-lactams. It is not known if GI1 and
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